• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国急性 ST 段抬高型心肌梗死患者的医院间护理差异与结局的关联。

Association of Hospital-Level Differences in Care With Outcomes Among Patients With Acute ST-Segment Elevation Myocardial Infarction in China.

机构信息

Coronary Heart Disease Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

Medical Research and Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

出版信息

JAMA Netw Open. 2020 Oct 1;3(10):e2021677. doi: 10.1001/jamanetworkopen.2020.21677.

DOI:10.1001/jamanetworkopen.2020.21677
PMID:33095249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7584928/
Abstract

IMPORTANCE

The incidence of acute myocardial infarction has increased over the past decades in China, and management challenges include an unbalanced economy, disparate resources, and variable access to medical care across the nation.

OBJECTIVE

To examine the variations in care and outcomes of patients with ST-segment elevation myocardial infarction among 3 levels of hospitals in the typical Chinese public hospital model.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the China Acute Myocardial Infarction Registry to compare the differences in care and outcomes among patients at 108 hospitals from 31 provinces and municipalities throughout mainland China. Participants included patients with ST-segment elevation myocardial infarction directly admitted to hospitals between January 2013 and September 2014. Data analyses were performed from June 2015 to June 2019.

EXPOSURES

Care in province-level, prefecture-level, or county-level hospitals in China.

MAIN OUTCOMES AND MEASURES

The primary outcome was in-hospital mortality. Secondary outcomes included presentation, treatments, and major complications.

RESULTS

A total of 12 695 patients (9593 men [75.6%]; median [interquartile range] age, 63 [54-72] years) were included; 3985 were at province-level hospitals, 6731 were at prefecture-level hospitals, and 1979 were at county-level hospitals. Compared with patients admitted to province-level hospitals, those admitted to prefecture-level and county-level hospitals were older (median [interquartile range] age, 61 [52-70] years vs 63 [54-72] years and 65 [57-75] years) and more likely to be women (815 women [20.5%] vs 1620 women [24.1%] and 667 women [33.7%]). Patients in prefecture-level and county-level hospitals were less likely to use ambulances compared with patients at province-level hospitals (11.6% [95% CI, 10.8%-12.4%] and 12.0% [95% CI, 10.6%-13.5%] vs 19.4% [95% CI, 18.1%-20.7%]; P < .001) and were less likely to experience early presentation, with onset-to-arrival times less than 12 hours for 75.3% (95% CI, 73.9%-76.6%) of patients at province-level hospitals, 70.8% (95% CI, 69.7%-71.9%) of patients at prefecture-level hospitals, and 69.8% (95% CI, 67.7%-71.8%) of patients at county-level hospitals (P < .001). The rates of reperfusion therapy were significantly lower in low-level hospitals (54.3% [95% CI, 53.1%-55.5%] for prefecture-level hospitals and 45.8% [95% CI, 43.6%-48.1%] for county-level hospitals) compared with province-level hospitals (69.4% [95% CI, 67.9%-70.8%]; P < .001). There was a progressively higher rate of in-hospital mortality at the 3 levels of hospitals: 3.1% (95% CI, 2.6%-3.7%) for province-level hospitals, 5.3% (95% CI, 4.8%-5.9%) for prefecture-level hospitals, and 10.2% (95% CI, 8.9%-11.7%) for county-level hospitals (P for trend < .001). After adjustment for patient characteristics, presentation, hospital facility, and treatments, the odds of death remained higher in prefecture-level (odds ratio, 1.39 [95% CI, 1.06-1.84]) and county-level (odds ratio, 1.43 [95% CI, 0.97-2.11]) hospitals compared with province-level hospitals (P for trend = .04).

CONCLUSIONS AND RELEVANCE

These findings suggest that there are significant variations in care and outcomes of patients among the 3 levels of hospitals in China. More efforts should be made to address the identified gaps, particularly in the prefecture-level and county-level hospitals. This work can inform national quality improvements efforts in China and in other developing countries.

摘要

重要性

过去几十年,中国急性心肌梗死的发病率有所上升,管理挑战包括经济不平衡、资源差异以及全国医疗服务获取的不平衡。

目的

在典型的中国公立医院模式下,比较三级医院中 ST 段抬高型心肌梗死患者的治疗差异及结局。

设计、地点和参与者:本横断面研究使用了中国急性心肌梗死注册研究的数据,比较了中国大陆 31 个省、直辖市的 108 家医院直接收治的 ST 段抬高型心肌梗死患者之间的治疗差异和结局。参与者包括直接收治入院的 ST 段抬高型心肌梗死患者,纳入时间为 2013 年 1 月至 2014 年 9 月。数据分析于 2015 年 6 月至 2019 年 6 月进行。

暴露因素

中国省级、市级或县级医院的治疗。

主要结局和措施

主要结局是院内死亡率。次要结局包括发病情况、治疗和主要并发症。

结果

共纳入 12695 例患者(9593 例男性[75.6%];中位数[四分位间距]年龄,63[54-72]岁),其中 3985 例来自省级医院,6731 例来自市级医院,1979 例来自县级医院。与省级医院相比,市级和县级医院的患者年龄更大(中位数[四分位间距]年龄,61[52-70]岁比 63[54-72]岁和 65[57-75]岁),女性患者比例更高(815 例女性[20.5%]比 1620 例女性[24.1%]和 667 例女性[33.7%])。与省级医院相比,市级和县级医院患者使用救护车的比例较低(11.6%[95%置信区间,10.8%-12.4%]和 12.0%[95%置信区间,10.6%-13.5%]比 19.4%[95%置信区间,18.1%-20.7%];P<0.001),且发病至就诊时间更晚,省级医院 75.3%(95%置信区间,73.9%-76.6%)的患者就诊时间在 12 小时以内,市级医院 70.8%(95%置信区间,69.7%-71.9%)的患者和县级医院 69.8%(95%置信区间,67.7%-71.8%)的患者就诊时间在 12 小时以内(P<0.001)。低级别医院的再灌注治疗率明显较低(市级医院 54.3%[95%置信区间,53.1%-55.5%]和县级医院 45.8%[95%置信区间,43.6%-48.1%]),与省级医院 69.4%(95%置信区间,67.9%-70.8%)相比,差异有统计学意义(P<0.001)。3 级医院的院内死亡率呈逐渐升高趋势:省级医院为 3.1%(95%置信区间,2.6%-3.7%),市级医院为 5.3%(95%置信区间,4.8%-5.9%),县级医院为 10.2%(95%置信区间,8.9%-11.7%)(P<0.001)。在调整了患者特征、发病情况、医院设施和治疗情况后,市级(比值比,1.39[95%置信区间,1.06-1.84])和县级(比值比,1.43[95%置信区间,0.97-2.11])医院的死亡风险仍高于省级医院(P<0.001)。

结论和意义

这些发现表明,中国 3 级医院之间在治疗和结局方面存在显著差异。应做出更多努力来解决这些差距,特别是在市级和县级医院。这项工作可以为中国和其他发展中国家的国家质量改进工作提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/7584928/5d9fada729ba/jamanetwopen-e2021677-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/7584928/7862f99c1ad8/jamanetwopen-e2021677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/7584928/434ce4f59293/jamanetwopen-e2021677-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/7584928/5d9fada729ba/jamanetwopen-e2021677-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/7584928/7862f99c1ad8/jamanetwopen-e2021677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/7584928/434ce4f59293/jamanetwopen-e2021677-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eea/7584928/5d9fada729ba/jamanetwopen-e2021677-g003.jpg

相似文献

1
Association of Hospital-Level Differences in Care With Outcomes Among Patients With Acute ST-Segment Elevation Myocardial Infarction in China.中国急性 ST 段抬高型心肌梗死患者的医院间护理差异与结局的关联。
JAMA Netw Open. 2020 Oct 1;3(10):e2021677. doi: 10.1001/jamanetworkopen.2020.21677.
2
Current Status and Hospital-Level Differences in Care and Outcomes of Patients With Acute Non-ST-Segment Elevation Myocardial Infarction in China: Insights From China Acute Myocardial Infarction Registry.中国急性非ST段抬高型心肌梗死患者的治疗现状及医院层面的护理与结局差异:来自中国急性心肌梗死注册研究的见解
Front Cardiovasc Med. 2022 Jan 17;8:800222. doi: 10.3389/fcvm.2021.800222. eCollection 2021.
3
A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: The Tamil Nadu-ST-Segment Elevation Myocardial Infarction Program.印度 ST 段抬高型心肌梗死患者的护理系统:泰米尔纳德邦 ST 段抬高型心肌梗死计划。
JAMA Cardiol. 2017 May 1;2(5):498-505. doi: 10.1001/jamacardio.2016.5977.
4
Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION Registry.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时心脏导管室预激活与再灌注时间指标和结局的关系:ACTION 注册研究的报告。
JACC Cardiovasc Interv. 2018 Sep 24;11(18):1837-1847. doi: 10.1016/j.jcin.2018.07.020.
5
Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry.中国接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的症状发作至球囊扩张时间、ST段回落情况及院内死亡率:来自中国急性心肌梗死注册研究
Am J Cardiol. 2016 Nov 1;118(9):1334-1339. doi: 10.1016/j.amjcard.2016.07.058. Epub 2016 Aug 13.
6
Comparison of In-Hospital Mortality and Length of Stay in Acute ST-Segment-Elevation Myocardial Infarction Among Urban Teaching Hospitals in China and the United States.中美城市教学医院急性 ST 段抬高型心肌梗死住院死亡率和住院时间比较。
J Am Heart Assoc. 2019 Nov 19;8(22):e012054. doi: 10.1161/JAHA.119.012054. Epub 2019 Nov 13.
7
Clinical Presentation, Quality of Care, Risk Factors and Outcomes in Women with Acute ST-Elevation Myocardial Infarction (STEMI): An Observational Report from Six Middle Eastern Countries.急性 ST 段抬高型心肌梗死(STEMI)女性患者的临床表现、护理质量、危险因素和结局:来自六个中东国家的观察性报告。
Curr Vasc Pharmacol. 2019;17(4):388-395. doi: 10.2174/1570161116666180315104820.
8
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.区域化 ST 段抬高型心肌梗死救治对接受经皮冠状动脉介入治疗的急救医疗服务转运患者的治疗时间和结局的影响:生命线加速 2 计划。
Circulation. 2018 Jan 23;137(4):376-387. doi: 10.1161/CIRCULATIONAHA.117.032446. Epub 2017 Nov 14.
9
Changes in ST segment elevation myocardial infarction hospitalisations in China from 2011 to 2015.2011 年至 2015 年中国 ST 段抬高型心肌梗死住院患者变化情况。
Open Heart. 2021 Sep;8(2). doi: 10.1136/openhrt-2021-001666.
10
Current Trends for ST-segment Elevation Myocardial Infarction during the Past 5 Years in Rural Areas of China's Liaoning Province: A Multicenter Study.中国辽宁省农村地区过去5年ST段抬高型心肌梗死的当前趋势:一项多中心研究
Chin Med J (Engl). 2017 Apr 5;130(7):757-766. doi: 10.4103/0366-6999.202742.

引用本文的文献

1
Development and validation of a nomogram model for prediction of dyslipidemia in children with Wilson disease: a retrospective analysis.肝豆状核变性患儿血脂异常预测列线图模型的建立与验证:一项回顾性分析
Front Endocrinol (Lausanne). 2025 Aug 21;16:1642083. doi: 10.3389/fendo.2025.1642083. eCollection 2025.
2
Acute myocardial infarction in a 16-year-old patient - A journey from death to life: Case report.一名16岁患者的急性心肌梗死——从死亡到生命的历程:病例报告
Medicine (Baltimore). 2025 Aug 22;104(34):e43975. doi: 10.1097/MD.0000000000043975.
3
Effects of communication, trust, and respect on shared decision-making: insights from healthcare providers in Chinese public hospitals.

本文引用的文献

1
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.死亡率、发病率和风险因素在中国及其省份,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 Sep 28;394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1. Epub 2019 Jun 24.
2
Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China: A Randomized Clinical Trial.中国资源受限医院中急性冠状动脉综合征患者的医疗质量改进措施的效果:一项随机临床试验。
JAMA Cardiol. 2019 May 1;4(5):418-427. doi: 10.1001/jamacardio.2019.0897.
3
沟通、信任和尊重对共同决策的影响:来自中国公立医院医护人员的见解
Front Med (Lausanne). 2025 Jun 18;12:1577276. doi: 10.3389/fmed.2025.1577276. eCollection 2025.
4
Multimorbidity Patterns and In-Hospital Outcomes in Chinese Young Women (Aged <55 Years) Presenting with ST-Segment-Elevation Myocardial Infarction.中国年轻女性(年龄<55岁)ST段抬高型心肌梗死的共病模式及院内结局
J Am Heart Assoc. 2025 Apr;14(7):e034124. doi: 10.1161/JAHA.124.034124. Epub 2025 Mar 27.
5
Pharmaco-Invasive Strategy with Half-Dose Recombinant Human Prourokinase Versus Primary Percutaneous Coronary Intervention.半剂量重组人尿激酶原药物介入策略与直接经皮冠状动脉介入治疗的对比
Anatol J Cardiol. 2025 Mar 4;29(4):164-72. doi: 10.14744/AnatolJCardiol.2025.4879.
6
Risk factors and an interpretability tool of in-hospital mortality in critically ill patients with acute myocardial infarction.急性心肌梗死危重症患者院内死亡的危险因素及可解释性工具
Clin Med (Lond). 2025 May;25(3):100299. doi: 10.1016/j.clinme.2025.100299. Epub 2025 Feb 27.
7
Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker-epicardial adipose tissue mass index: a prospective cohort study.使用心脏肥胖标志物——心外膜脂肪组织质量指数预测ST段抬高型心肌梗死患者的主要不良心血管事件:一项前瞻性队列研究。
Front Cardiovasc Med. 2025 Feb 12;12:1539500. doi: 10.3389/fcvm.2025.1539500. eCollection 2025.
8
Predictive Value of Lung Ultrasound Combined With ACEF Score for the Prognosis of Acute Myocardial Infarction.肺部超声联合ACEF评分对急性心肌梗死预后的预测价值
Clin Cardiol. 2025 Feb;48(2):e70077. doi: 10.1002/clc.70077.
9
Neutrophil to platelet ratio predicts in-hospital mortality in patients with acute myocardial infarction.中性粒细胞与血小板比值可预测急性心肌梗死患者的院内死亡率。
Intern Emerg Med. 2025 Apr;20(3):723-731. doi: 10.1007/s11739-025-03859-w. Epub 2025 Jan 21.
10
Prognosis in Patients with ST-Segment Elevation Myocardial Infarction Reperfused by PHDP: 1-Year MACEs Follow-Up.PHDP 再灌注治疗 ST 段抬高型心肌梗死患者的预后:1 年 MACCE 随访。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241271394. doi: 10.1177/10760296241271394.
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.
区域化 ST 段抬高型心肌梗死救治对接受经皮冠状动脉介入治疗的急救医疗服务转运患者的治疗时间和结局的影响:生命线加速 2 计划。
Circulation. 2018 Jan 23;137(4):376-387. doi: 10.1161/CIRCULATIONAHA.117.032446. Epub 2017 Nov 14.
4
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.在过去的 20 年中,ST 段抬高型心肌梗死患者的治疗效果得到了改善,这与循证治疗的实施有关:来自 1995-2014 年 SWEDEHEART 注册研究的经验。
Eur Heart J. 2017 Nov 1;38(41):3056-3065. doi: 10.1093/eurheartj/ehx515.
5
Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.全球 ST 段抬高型心肌梗死管理和出院后死亡率的地域差异。
Int J Cardiol. 2017 Oct 15;245:27-34. doi: 10.1016/j.ijcard.2017.07.039. Epub 2017 Jul 15.
6
Age-Specific Trends in the Incidence and In-Hospital Mortality of Acute Myocardial Infarction Over 30 Years in Japan - Report From the Miyagi AMI Registry Study.日本30年间急性心肌梗死发病率和院内死亡率的年龄特异性趋势——宫城急性心肌梗死登记研究报告
Circ J. 2017 Mar 24;81(4):520-528. doi: 10.1253/circj.CJ-16-0799. Epub 2017 Feb 2.
7
Mortality due to acute myocardial infarction in China from 1987 to 2014: Secular trends and age-period-cohort effects.1987年至2014年中国急性心肌梗死死亡率:长期趋势及年龄-时期-队列效应
Int J Cardiol. 2017 Jan 15;227:229-238. doi: 10.1016/j.ijcard.2016.11.130. Epub 2016 Nov 8.
8
A new cooperative approach for ST-elevation myocardial infarction patients to receive timely and effective percutaneous coronary reperfusion in China.一种在中国为ST段抬高型心肌梗死患者提供及时有效经皮冠状动脉再灌注的新合作方法。
J Geriatr Cardiol. 2016 Jul;13(7):602-7. doi: 10.11909/j.issn.1671-5411.2016.07.013.
9
STEMI in India.印度的ST段抬高型心肌梗死
Eur Heart J. 2016 Aug;37(31):2449-53. doi: 10.1093/eurheartj/ehw279.
10
Acute myocardial infarction.急性心肌梗死。
Lancet. 2017 Jan 14;389(10065):197-210. doi: 10.1016/S0140-6736(16)30677-8. Epub 2016 Aug 5.